LD TECHNOLOGY

ANS-1 SYSTEM

Early Detection of Disease Complications - LD Technology

ANS-1 system integrates 3 technologies based on Galvanic skin response, photoplethysmography analysis and oscillometry to assess the Autonomic Nervous System and Peripheral circulation.

TECHNOLOGIES :

GALVANIC SKIN RESPONSE+ OSCILLOMETRY + PHOTOPLETHYSMOGRAPHY

ANS-1 Software manages 2 hardware’s: SweatC Model A001 and TM-Oxi Model B001.

ANS-1 System manages the Autonomic Nervous System battery of tests recommended by the American Academy of Neurology since 1996, and the Cardiovascular Autonomic Neuropathy Subcommittee of the Toronto Consensus Panel on Diabetic Neuropathy, for assessing the Autonomic Nervous System.
 
Autonomic testing is recommended for all patients with type 2 diabetes at the time of the diagnosis, and 5 years after diagnosis in individuals with type 1 diabetes.
(Boulton et al., 2005;Tesfaye et al., 2010;Spallone et al., 2011; Bernardi et al.,2011.)
ANS-1

BENEFITS

Simultaneous measurement

FAST TESTS

No Human
Error

Accurate
Results

Clear
Reports

ANS and Artery overview

TM-FLOW

MARKERS

Vascular function Assessment :

ANS Assessment :

Endothelial Markers :

ANS-1 FEATURES :

Early Detection of Disease Complications - LD Technology
ANS-1

PATIENT SETUP

Early Detection of Disease Complications - LD Technology
Early Detection of Disease Complications - LD Technology
Early Detection of Disease Complications - LD Technology

ANS-1 REVIEW BY DR. JIMMY NINH

DISCOVER PRODUCTS CATALOG